Candidate marker vaccine strain with HQ06 epitope mutation for swine fever and application of candidate marker vaccine strain

A swine fever and epitope technology, applied in vaccines, veterinary vaccines, medical preparations containing active ingredients, etc., can solve the problems of not being able to distinguish between wild virus infection and vaccination, limiting swine fever purification, etc.

Pending Publication Date: 2021-07-13
HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, at the current stage, the attenuated CSF vaccine C strain does not have the characteristics of distinguishing betw

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Candidate marker vaccine strain with HQ06 epitope mutation for swine fever and application of candidate marker vaccine strain
  • Candidate marker vaccine strain with HQ06 epitope mutation for swine fever and application of candidate marker vaccine strain
  • Candidate marker vaccine strain with HQ06 epitope mutation for swine fever and application of candidate marker vaccine strain

Examples

Experimental program
Comparison scheme
Effect test
No Example Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a candidate marker vaccine strain with HQ06 epitope mutation for swine fever and an application of the candidate marker vaccine strain. According to the invention, a C strain is used as a skeleton, and three mutant viruses are constructed by single point mutation of three key amino acids 117F, 119G and 122P of E2 protein HQ06 antigen epitopes. The three mutant viruses constructed by the invention lose reactivity with a monoclonal antibody (mAb) HQ06 and retain reactivity with other antigen sites of the CSFV E2 protein, and biological characteristics of the three mutant viruses are consistent with those of a C strain; wherein the rHCLV-E2P122A can reach the growth titer of a parent virus in vitro, can induce an organism to generate an antibody aiming at the CSFV E2 and a neutralizing antibody aiming at the CSFV in rabbit and pig bodies, but loses a specific antibody aiming at the HQ06 epitope for inducing the organism to generate, and the rHCLV-E2P122A strain disclosed by the invention can be developed into a swine fever labeled vaccine.

Description

technical field [0001] The invention relates to a CSF marker vaccine strain, in particular to a CSF candidate marker vaccine strain with HQ06 epitope mutation and application thereof, and belongs to the field of CSF marker vaccine strains. Background technique [0002] Classical swine fever (CSF) is a highly contagious disease of pigs characterized by high fever and extensive hemorrhage, which has caused huge economic losses to the pig industry in many countries in the world. The World Organization for Animal Health (OIE) included it in the list of OIE animal diseases that must be declared (Notifiable). China's "National Medium and Long-Term Animal Disease Prevention and Control Plan (2012-2020)" lists swine fever as one of the five priority "Class I animal diseases" for prevention and control. [0003] Classical swine fever virus (CSFV), the pathogen of CSF, is a member of the genus Pestivirus in the family Flaviviridae. CSFV is a single-stranded positive-sense RNA virus ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/00C12N15/63C12N5/10A61K39/187A61P31/14
CPCC12N7/00A61K39/12A61P31/14C12N2770/24321C12N2770/24334A61K2039/552
Inventor 仇华吉李永锋韩玉莹孙元罗玉子李素
Owner HARBIN VETERINARY RES INST CHINESE ACADEMY OF AGRI SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products